Ticos Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 11-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 11-12-2024
- Company Age 16 Year, 9 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 1.67 Cr
as on 11-12-2024
- Revenue -33.37%
(FY 2022)
- Profit 80.85%
(FY 2022)
- Ebitda -33.71%
(FY 2022)
- Net Worth -12.34%
(FY 2022)
- Total Assets -9.13%
(FY 2022)
About Ticos Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹1.67 Cr.
Jaynesh Patel, Payal Patel, Sureshkumar Parmar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PLC053283
- Company No.
053283
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Mar 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Ticos Lifesciences Limited offer?
Ticos Lifesciences Limited offers a wide range of products and services, including Infusion Syringes & Supplies, Catheter, Surgical Needles, Spinal Needle, Personal Protective Equipment, PPE Kits, Common Disease Medicines, Cough Syrup.
Who are the key members and board of directors at Ticos Lifesciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaynesh Patel  | Director | 18-Mar-2008 | Current |
| Payal Patel | Director | 22-Jul-2011 | Current |
| Sureshkumar Parmar | Director | 11-Jun-2019 | Current |
| Pravinchandra Bhuva | Additional Director | 19-Nov-2022 | Current |
Financial Performance of Ticos Lifesciences.
Ticos Lifesciences Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 33.37% decrease. The company also saw a substantial improvement in profitability, with a 80.85% increase in profit. The company's net worth observed a substantial decline by a decrease of 12.34%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ticos Lifesciences?
In 2022, Ticos Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ticos Omega Pharmaceuticals Private LimitedActive 4 years 10 months
Jaynesh Patel and Payal Patel are mutual person
- Ticos Laboratories Private LimitedActive 14 years 8 months
Jaynesh Patel and Payal Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 06 Mar 2012 | ₹1.67 Cr | Open |
How Many Employees Work at Ticos Lifesciences?
Unlock and access historical data on people associated with Ticos Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ticos Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ticos Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
